Wednesday 30 August 2017

China Cancer Test Market : Market Share, Trends, Insight and Application 2017

ResearchMoz presents professional and in-depth study of "China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022".

As per Renub Research analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022. In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness against cancer and the promotion of healthy lifestyle have also been carried out actively.

Growing Lung Cancer out of 26 Cancer Cases Studied in the Report

Cancer is one of the most significant public health burdens in China. China has exceptional number of lung cancer diagnoses and deaths than any other part of the world. The problem will keep mounting in near future as China’ air pollution goes mostly unchecked. In total 26 types of Cancer market and number of cases have been studied in the report. 

Lung Cancer dominates the China Oncology (Cancer) Screening Tests Market and Volume

In Male: Lung Cancer is the most predominant cancer, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order).

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1312569

In Female: Other than Lung, Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma.

High Cancer Mortality Rates

Cancer mortality rates in China have been rising rapidly over the past three decades. In urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

Renub Research report titled “China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022” studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

China Cancer (Oncology) Screening Tests Market & Forecast

    Male
    Female

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=1312569

China Cancer (Oncology) Screening Tests Volume & Forecast

    Male
    Female

China Cancer (Oncology) Mortality Rate

All the 26 Cancer Market & Cases Studied in the Report are as Follows:

    Lip, oral cavity, & pharynx (except nasopharynx)
    Nasopharynx
    Esophagus
    Stomach
    Colorectum
    Liver
    Gallbladder
    Pancreas
    Larynx
    Lung
    Other thoracic organs
    Bone
    Melanoma of the skin
    Breast
    Cervix
    Uterus

Browse Report @ http://www.researchmoz.us/china-cancer-test-market-volume-forecast-by-male-female-mortality-26-cancer-oncology-types-market-volume-to-2022-report.html

    Ovary
    Prostate
    Testis
    Kidney
    Bladder
    Brain, CNS
    Thyroid
    Lymphoma
    Leukemia
    All other sites and unspecified

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

No comments:

Post a Comment